| Literature DB >> 25949899 |
Steven N Seyedin1, Chad Tang1, James W Welsh1.
Abstract
The ability of tumors to evade detection by the immune system via inducing immunosuppression prompted the therapeutic development of immune checkpoint inhibitors. In our recent review, we discussed findings from preclinical and clinical investigations of these agents utilized in combination with radiation inducing abscopal (systemic) antitumor effects.Entities:
Keywords: CTLA4; PD1; PDL1; abscopal effect; antibodies; immune checkpoint inhibitors; radiation therapy
Year: 2015 PMID: 25949899 PMCID: PMC4404906 DOI: 10.4161/2162402X.2014.986402
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110